The IL-17A/IL-17RA axis in pulmonary defence and immunopathology

Cytokine and Growth Factor Reviews

Volumn 30, Issue , 2016, Pages 19-27

  Lorè, Nicola Ivan ^a   Bragonzi, Alessandra ^a   Cigana, Cristina ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Host defence; Immunopathology; Interleukin (IL) 17 receptor A; Interleukin (IL) 17A

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR A; UNCLASSIFIED DRUG; IL17A PROTEIN, HUMAN; IL17RA PROTEIN, HUMAN; INTERLEUKIN 17 RECEPTOR;

ADAPTIVE IMMUNITY; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; GAMMA DELTA T LYMPHOCYTE; HOST RESISTANCE; HUMAN; IMMUNOPATHOLOGY; LUNG DEFENCE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH17 CELL; ANIMAL; IMMUNOLOGY; LUNG; LUNG DISEASE; RESPIRATORY TRACT INFECTION;

ANIMALS; HUMANS; INTERLEUKIN-17; LUNG; LUNG DISEASES; RECEPTORS, INTERLEUKIN-17; RESPIRATORY TRACT INFECTIONS; SIGNAL TRANSDUCTION;

EID: 84969968153     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2016.03.009     Document Type: Short Survey

References (95)

1. [1] Rouvier, E., Luciani, M.F., Mattei, M.G., Denizot, F., Golstein, P., CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150 (1993), 5445–5456.
2. [2] Iwakura, Y., Ishigame, H., Saijo, S., Nakae, S., Functional specialization of interleukin-17 family members. Immunity 34 (2011), 149–162.
3. [3] Wright, J.F., Bennett, F., Li, B., Brooks, J., Luxenberg, D.P., Whitters, M.J., et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J. Immunol. 181 (2008), 2799–2805.
4. [4] Kang, Z., Swaidani, S., Yin, W., Wang, C., Barlow, J.L., Gulen, M.F., et al. Epithelial cell-specific Act1 adaptor mediates interleukin-25-dependent helminth expulsion through expansion of Lin(−)c-Kit(+) innate cell population. Immunity 36 (2012), 821–833.
5. [5] Ramirez-Carrozzi, V., Sambandam, A., Luis, E., Lin, Z., Jeet, S., Lesch, J., et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat. Immunol. 12 (2011), 1159–1166.
6. [6] Starnes, T., Broxmeyer, H.E., Robertson, M.J., Hromas, R., Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol. 169 (2002), 642–646.
7. [7] Reynolds, J.M., Lee, Y.H., Shi, Y., Wang, X., Angkasekwinai, P., Nallaparaju, K.C., et al. Interleukin-17B antagonizes interleukin-25-Mediated mucosal inflammation. Immunity 42 (2015), 692–703.
8. [8] Wu, H.H., Hwang-Verslues, W.W., Lee, W.H., Huang, C.K., Wei, P.C., Chen, C.L., et al. Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines. J. Exp. Med. 212 (2015), 333–349.
9. [9] Mellett, M., Atzei, P., Horgan, A., Hams, E., Floss, T., Wurst, W., et al. Orphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophilia. Nat. Commun., 3, 2012, 1119.
10. [10] Yang, S., Wang, Y., Mei, K., Zhang, S., Sun, X., Ren, F., et al. Tumor necrosis factor receptor 2 (TNFR2).interleukin-17 receptor D (IL-17RD) heteromerization reveals a novel mechanism for NF-kappaB activation. J. Biol. Chem. 290 (2015), 861–871.
11. [11] Yen, H.R., Harris, T.J., Wada, S., Grosso, J.F., Getnet, D., Goldberg, M.V., et al. Tc17CD8 T cells: functional plasticity and subset diversity. J. Immunol. 183 (2009), 7161–7168.
12. [12] Lee, Y., Awasthi, A., Yosef, N., Quintana, F.J., Xiao, S., Peters, A., et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13 (2012), 991–999.
13. [13] Harrington, L.E., Hatton, R.D., Mangan, P.R., Turner, H., Murphy, T.L., Murphy, K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6 (2005), 1123–1132.
14. [14] Gaffen, S.L., Jain, R., Garg, A.V., Cua, D.J., The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14 (2014), 585–600.
15. [15] Liang, S.C., Long, A.J., Bennett, F., Whitters, M.J., Karim, R., Collins, M., et al. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J. Immunol. 179 (2007), 7791–7799.
16. [16] Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M., Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006), 179–189.
17. [17] Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006), 235–238.
18. [18] Gulen, M.F., Kang, Z., Bulek, K., Youzhong, W., Kim, T.W., Chen, Y., et al. The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity 32 (2010), 54–66.
19. [19] Mills, K.H., Dungan, L.S., Jones, S.A., Harris, J., The role of inflammasome-derived IL-1 in driving IL-17 responses. J. Leukoc. Biol. 93 (2013), 489–497.
20. [20] Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jager, A., Strom, T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448 (2007), 484–487.
21. [21] Nurieva, R., Yang, X.O., Martinez, G., Zhang, Y., Panopoulos, A.D., Ma, L., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448 (2007), 480–483.
22. [22] Ivanov, I.I., McKenzie, B.S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille, J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 (2006), 1121–1133.
23. [23] Yang, X.O., Pappu, B.P., Nurieva, R., Akimzhanov, A., Kang, H.S., Chung, Y., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28 (2008), 29–39.
24. [24] Brustle, A., Heink, S., Huber, M., Rosenplanter, C., Stadelmann, C., Yu, P., et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8 (2007), 958–966.
25. [25] Ciofani, M., Madar, A., Galan, C., Sellars, M., Mace, K., Pauli, F., et al. A validated regulatory network for Th17 cell specification. Cell 151 (2012), 289–303.
26. [26] Glasmacher, E., Agrawal, S., Chang, A.B., Murphy, T.L., Zeng, W., Vander Lugt, B., et al. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science 338 (2012), 975–980.
27. [27] Schraml, B.U., Hildner, K., Ise, W., Lee, W.L., Smith, W.A., Solomon, B., et al. The AP-1 transcription factor batf controls T(H)17 differentiation. Nature 460 (2009), 405–409.
28. [28] Bauquet, A.T., Jin, H., Paterson, A.M., Mitsdoerffer, M., Ho, I.C., Sharpe, A.H., et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10 (2009), 167–175.
29. [29] Ruan, Q., Kameswaran, V., Zhang, Y., Zheng, S., Sun, J., Wang, J., et al. The Th17 immune response is controlled by the Rel-RORgamma-RORgamma T transcriptional axis. J. Exp. Med. 208 (2011), 2321–2333.
30. [30] Veldhoen, M., Hirota, K., Westendorf, A.M., Buer, J., Dumoutier, L., Renauld, J.C., et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453 (2008), 106–109.
31. [31] Korn, T., Bettelli, E., Oukka, M., Kuchroo, V.K., IL-17 and Th17Cells. Annu. Rev. Immunol. 27 (2009), 485–517.
32. [32] Littman, D.R., Rudensky, A.Y., Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140 (2010), 845–858.
33. [33] Konigshofer, Y., Chien Gammadelta, Y.H., T cells—innate immune lymphocytes. Curr. Opin. Immunol. 18 (2006), 527–533.
34. [34] Schmolka, N., Wencker, M., Hayday, A.C., Silva-Santos, B., Epigenetic and transcriptional regulation of gammadelta T cell differentiation: programming cells for responses in time and space. Semin. Immunol. 27 (2015), 19–25.
35. [35] Hirota, K., Duarte, J.H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D.J., et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12 (2011), 255–263.
36. [36] Sutton, C.E., Mielke, L.A., Mills, K.H., IL-17-producing gammadelta T cells and innate lymphoid cells. Eur. J. Immunol. 42 (2012), 2221–2231.
37. [37] Lalor, S.J., Dungan, L.S., Sutton, C.E., Basdeo, S.A., Fletcher, J.M., Mills, K.H., Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. J. Immunol. 186 (2011), 5738–5748.
38. [38] Michel, M.L., Pang, D.J., Haque, S.F., Potocnik, A.J., Pennington, D.J., Hayday, A.C., Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing gammadelta cells. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 17549–17554.
39. [39] Martin, B., Hirota, K., Cua, D.J., Stockinger, B., Veldhoen, M., Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31 (2009), 321–330.
40. [40] Serre, K., Silva-Santos, B., Molecular mechanisms of differentiation of murine pro-Inflammatory gammadelta t cell subsets. Front. Immunol., 4, 2013, 431.
41. [41] Godfrey, D.I., Stankovic, S., Baxter, A.G., Raising the NKT cell family. Nat. Immunol. 11 (2010), 197–206.
42. [42] Monteiro, M., Almeida, C.F., Agua-Doce, A., Graca, L., Induced IL-17-producing invariant NKT cells require activation in presence of TGF-beta and IL-1beta. J. Immunol. 190 (2013), 805–811.
43. [43] Webster, K.E., Kim, H.O., Kyparissoudis, K., Corpuz, T.M., Pinget, G.V., Uldrich, A.P., et al. IL-17-producing NKT cells depend exclusively on IL-7 for homeostasis and survival. Mucosal Immunol. 7 (2014), 1058–1067.
44. [44] Michel, M.L., Keller, A.C., Paget, C., Fujio, M., Trottein, F., Savage, P.B., et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204 (2007), 995–1001.
45. [45] Siegmann, N., Worbs, D., Effinger, F., Bormann, T., Gebhardt, M., Ulrich, M., et al. Invariant natural killer T (iNKT) cells prevent autoimmunity, but induce pulmonary inflammation in cystic fibrosis. Cell. Physiol. Biochem. 34 (2014), 56–70.
46. [46] Artis, D., Spits, H., The biology of innate lymphoid cells. Nature 517 (2015), 293–301.
47. [47] Constantinides, M.G., McDonald, B.D., Verhoef, P.A., Bendelac, A., A committed precursor to innate lymphoid cells. Nature 508 (2014), 397–401.
48. [48] Klose, C.S., Flach, M., Mohle, L., Rogell, L., Hoyler, T., Ebert, K., et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157 (2014), 340–356.
49. [49] Sonnenberg, G.F., Artis, D., Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat. Med. 21 (2015), 698–708.
50. [50] Passos, S.T., Silver, J.S., O'Hara, A.C., Sehy, D., Stumhofer, J.S., Hunter, C.A., IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J. Immunol. 184 (2010), 1776–1783.
51. [51] Muir, R., Osbourn, M., Dubois, A.V., Doran, E., Small, D.M., Monahan, A., et al. Innate lymphoid cells are the predominant source of interleukin-17A during the early pathogenesis of acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med., 2015.
52. [52] Pitt, J.M., Stavropoulos, E., Redford, P.S., Beebe, A.M., Bancroft, G.J., Young, D.B., et al. Blockade of IL-10 signaling during bacillus Calmette-Guerin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-gamma and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. J. Immunol. 189 (2012), 4079–4087.
53. [53] Taylor, P.R., Roy, S., Leal, S.M. Jr., Sun, Y., Howell, S.J., Cobb, B.A., et al. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nat. Immunol. 15 (2014), 143–151.
54. [54] Cai, S., Batra, S., Langohr, I., Iwakura, Y., Jeyaseelan, S., IFN-gamma induction by neutrophil-derived IL-17A homodimer augments pulmonary antibacterial defense. Mucosal Immunol., 2015, 10.1038/mi.2015.95.
55. [55] Gaffen, S.L., Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9 (2009), 556–567.
56. [56] Halwani, R., Al-Kufaidy, R., Vazquez-Tello, A., Pureza, M.A., BaHammam, A.S., Al-Jahdali, H., et al. IL-17 enhances chemotaxis of primary human B cells during asthma. PLoS One, 9, 2014, e114604.
57. [57] Ota, K., Kawaguchi, M., Matsukura, S., Kurokawa, M., Kokubu, F., Fujita, J., et al. Potential involvement of IL-17F in asthma. J. Immunol. Res., 2014, 2014, 602846.
58. [58] Kuestner, R.E., Taft, D.W., Haran, A., Brandt, C.S., Brender, T., Lum, K., et al. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J. Immunol. 179 (2007), 5462–5473.
59. [59] Zaretsky, M., Etzyoni, R., Kaye, J., Sklair-Tavron, L., Aharoni, A., Directed evolution of a soluble human IL-17A receptor for the inhibition of psoriasis plaque formation in a mouse model. Chem. Biol. 20 (2013), 202–211.
60. [60] Sohda, M., Misumi, Y., Tashiro, K., Yamazaki, M., Saku, T., Oda, K., Identification of a soluble isoform of human IL-17RA generated by alternative splicing. Cytokine 64 (2013), 642–645.
61. [61] Maitra, A., Shen, F., Hanel, W., Mossman, K., Tocker, J., Swart, D., et al. Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 7506–7511.
62. [62] Qian, Y., Liu, C., Hartupee, J., Altuntas, C.Z., Gulen, M.F., Jane-Wit, D., et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8 (2007), 247–256.
63. [63] Tsai, H.C., Velichko, S., Hung, L.Y., Wu, R., IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection. Clin. Dev. Immunol., 2013, 2013, 267971.
64. [64] McAleer, J.P., Kolls, J.K., Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense. Immunol. Rev. 260 (2014), 129–144.
65. [65] Medzhitov, R., Schneider, D.S., Soares, M.P., Disease tolerance as a defense strategy. Science 335 (2012), 936–941.
66. [66] Raberg, L., Graham, A.L., Read, A.F., Decomposing health: tolerance and resistance to parasites in animals. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 364 (2009), 37–49.
67. [67] Schneider, D.S., Ayres, J.S., Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat. Rev. Immunol. 8 (2008), 889–895.
68. [68] Read, A.F., Graham, A.L., Raberg, L., Animal defenses against infectious agents: is damage control more important than pathogen control. PLoS Biol., 6, 2008, e4.
69. [69] Ye, P., Rodriguez, F.H., Kanaly, S., Stocking, K.L., Schurr, J., Schwarzenberger, P., et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194 (2001), 519–527.
70. [70] Liu, J., Qu, H., Li, Q., Ye, L., Ma, G., Wan, H., The responses of gammadelta T-cells against acute Pseudomonas aeruginosa pulmonary infection in mice via interleukin-17. Pathog. Dis. 68 (2013), 44–51.
71. [71] Dubin, P.J., Martz, A., Eisenstatt, J.R., Fox, M.D., Logar, A., Kolls, J.K., Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 80 (2012), 398–409.
72. [72] Tam, S., Maksaereekul, S., Hyde, D.M., Godinez, I., Beaman, B.L., IL-17 and gammadelta T-lymphocytes play a critical role in innate immunity against Nocardia asteroides GUH-2. Microbes Infect. 14 (2012), 1133–1143.
73. [73] Okamoto Yoshida, Y., Umemura, M., Yahagi, A., O'Brien, R.L., Ikuta, K., Kishihara, K., et al. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J. Immunol. 184 (2010), 4414–4422.
74. [74] Gopal, R., Monin, L., Slight, S., Uche, U., Blanchard, E., Fallert Junecko, B.A., et al. Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. PLoS Pathog., 10, 2014, e1004099.
75. [75] Zhou, X., Chen, Q., Moore, J., Kolls, J.K., Halperin, S., Wang, J., Critical role of the interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species. Infect. Immun. 77 (2009), 5059–5070.
76. [76] Crowe, C.R., Chen, K., Pociask, D.A., Alcorn, J.F., Krivich, C., Enelow, R.I., et al. Critical role of IL-17RA in immunopathology of influenza infection. J. Immunol. 183 (2009), 5301–5310.
77. [77] Chesne, J., Braza, F., Mahay, G., Brouard, S., Aronica, M., Magnan, A., IL-17 in severe asthma. Where do we stand?. Am. J. Respir. Crit. Care Med. 190 (2014), 1094–1101.
78. [78] Woodruff, P.G., Modrek, B., Choy, D.F., Jia, G., Abbas, A.R., Ellwanger, A., et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 180 (2009), 388–395.
79. [79] Finkelman, F.D., Hogan, S.P., Hershey, G.K., Rothenberg, M.E., Wills-Karp, M., Importance of cytokines in murine allergic airway disease and human asthma. J. Immunol. 184 (2010), 1663–1674.
80. [80] Bullens, D.M., Truyen, E., Coteur, L., Dilissen, E., Hellings, P.W., Dupont, L.J., et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?. Respir. Res., 7, 2006, 135.
81. [81] Chen, J., Deng, Y., Zhao, J., Luo, Z., Peng, W., Yang, J., et al. The polymorphism of IL-17 G-152A was associated with childhood asthma and bacterial colonization of the hypopharynx in bronchiolitis. J. Clin. Immunol. 30 (2010), 539–545.
82. [82] Kudo, M., Melton, A.C., Chen, C., Engler, M.B., Huang, K.E., Ren, X., et al. IL-17A produced by alphabeta T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat. Med. 18 (2012), 547–554.
83. [83] Chang, Y., Al-Alwan, L., Risse, P.A., Halayko, A.J., Martin, J.G., Baglole, C.J., et al. Th17-associated cytokines promote human airway smooth muscle cell proliferation. FASEB J. 26 (2012), 5152–5160.
84. [84] Manni, M.L., Robinson, K.M., Alcorn, J.F., A tale of two cytokines: IL-17 and IL-22 in asthma and infection. Expert Rev. Respir. Med. 8 (2014), 25–42.
85. [85] Chang, Y., Al-Alwan, L., Risse, P.A., Roussel, L., Rousseau, S., Halayko, A.J., et al. TH17 cytokines induce human airway smooth muscle cell migration. J. Allergy Clin. Immunol. 127 (2011), 1046–1053 e1–2.
86. [86] Chen, K., Pociask, D.A., McAleer, J.P., Chan, Y.R., Alcorn, J.F., Kreindler, J.L., et al. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One, 6, 2011, e20333.
87. [87] Roos, A.B., Sethi, S., Nikota, J., Wrona, C.T., Dorrington, M.G., Sanden, C., et al. IL-17A and the promotion of neutrophilia in acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 192 (2015), 428–437.
88. [88] Roos, A.B., Sanden, C., Mori, M., Bjermer, L., Stampfli, M.R., Erjefalt, J.S., IL-17A is elevated in end-Stage chronic obstructive pulmonary disease and contributes to cigarette smoke-induced lymphoid neogenesis. Am. J. Respir. Crit. Care Med. 191 (2015), 1232–1241.
89. [89] McAllister, F., Henry, A., Kreindler, J.L., Dubin, P.J., Ulrich, L., Steele, C., et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J. Immunol. 175 (2005), 404–412.
90. [90] Decraene, A., Willems-Widyastuti, A., Kasran, A., De Boeck, K., Bullens, D.M., Dupont, L.J., Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients. Respir. Res., 11, 2010, 177.
91. [91] Tiringer, K., Treis, A., Fucik, P., Gona, M., Gruber, S., Renner, S., et al. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am. J. Respir. Crit. Care Med. 187 (2013), 621–629.
92. [92] Tan, H.L., Regamey, N., Brown, S., Bush, A., Lloyd, C.M., Davies, J.C., The Th17 pathway in cystic fibrosis lung disease. Am. J. Respir. Crit. Care Med. 184 (2011), 252–258.
93. [93] Gasse, P., Riteau, N., Vacher, R., Michel, M.L., Fautrel, A., di Padova, F., et al. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS One, 6, 2011, e23185.
94. [94] Hasan, S.A., Eksteen, B., Reid, D., Paine, H.V., Alansary, A., Johannson, K., et al. Role of IL-17A and neutrophils in fibrosis in experimental hypersensitivity pneumonitis. J. Allergy Clin. Immunol. 131 (2013), 1663–1673.
95. [95] Busse, W.W., Holgate, S., Kerwin, E., Chon, Y., Feng, J., Lin, J., et al. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am. J. Respir. Crit. Care Med. 188 (2013), 1294–1302.